Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wockhardt Of India Said Discussing Biotech Division Sale To Pfizer

This article was originally published in PharmAsia News

Executive Summary

India's Wockhardt is in serious discussions with U.S.-based Pfizer's bid to acquire the Indian drug maker's biotechnology and veterinary divisions. Under the deal being discussed, according to sources, is a Wockhardt spin-off of those two divisions into separate companies and then Pfizer purchasing them. One executive said the deal could be signed by the end of June. Wockhardt is said to be seeking funds to pay off some of its major debt load. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts